StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
VITA 34 AG
XETRA:V3V.DE
Sector
Industries
Location
Market Cap
USD 85.35 M
Share Price
USD 4.90
Avg Daily Volume
1,960
Change (1 day)
-4.91%
Change (1 year)
1.55%
Change (YTD)
14.21%
VITA 34 AG Free Cash Flow for the year ending December 31, 2023: USD 5.59 M
VITA 34 AG Free Cash Flow is USD 5.59 M for the year ending December 31, 2023, a -147.84% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
-
VITA 34 AG Free Cash Flow for the year ending December 31, 2022 was USD -11.68 M, a -2,297.20% change year over year.
-
VITA 34 AG Free Cash Flow for the year ending December 31, 2021 was USD 531.61 K, a -86.95% change year over year.
-
VITA 34 AG Free Cash Flow for the year ending December 31, 2020 was USD 4.07 M, a -33.61% change year over year.
-
VITA 34 AG Free Cash Flow for the year ending December 31, 2019 was USD 6.14 M, a 41.62% change year over year.
Competitors
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Thermo Fisher Scientific Inc.
USD 429.33
TMO
+1.57
0.37%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Boston Scientific Corporation
USD 104.32
BSX
+0.69
0.67%
Danaher Corporation
USD 203.20
DHR
+0.70
0.35%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 49.30
4519.T
+0.76
1.57%
CSL Limited
USD 158.90
CSL.AX
+0.55
0.35%
GSK plc
USD 19.16
GSK.L
+0.13
0.68%
Zoetis Inc.
USD 159.18
ZTS
+0.10
0.06%
Key Data
| Date | Free Cash Flow | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities |
|---|
Competitors
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Thermo Fisher Scientific Inc.
USD 429.33
TMO
+1.57
0.37%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Boston Scientific Corporation
USD 104.32
BSX
+0.69
0.67%
Danaher Corporation
USD 203.20
DHR
+0.70
0.35%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 49.30
4519.T
+0.76
1.57%
CSL Limited
USD 158.90
CSL.AX
+0.55
0.35%
GSK plc
USD 19.16
GSK.L
+0.13
0.68%
Zoetis Inc.
USD 159.18
ZTS
+0.10
0.06%